埃塞俄比亚严重精神障碍任务分担照护的疗效与成本效果(TaSCS):单盲、随机、对照、3期非劣效性试验
在埃塞俄比亚农村,329例严重精神障碍(精神病性或情感性障碍)患者随机接受任务分担照护(TSC,由受督导的非医师初级卫生保健工作者提供)或增强型专科精神科护理(PSY)。12个月时,TSC组BPRS-E均分27.7(SD 4.7) vs PSY组27.8(SD 4.6),调整后均差0.06(90% CI -0.80至0.89),无非劣效性证据。TSC增量成本效果比为每单位BPRS-E评分增加节省299.82美元(95% CI -454.95至-144.69)。
要点
- 12个月时TSC组BPRS-E均分27.7(SD 4.7) vs PSY组27.8(SD 4.6),调整后均差0.06(90% CI -0.80至0.89),无非劣效性证据。
- TSC组发生18例严重不良事件,PSY组29例,共涉及28名参与者。
- TSC增量成本效果比为每单位BPRS-E评分增加节省299.82美元(95% CI -454.95至-144.69)。
核心结论
- WHO精神卫生差距行动规划用于严重精神障碍时与现有专科照护模式具有同等成本效果,在资源匮乏地区可由受督导的非专科人员有效且安全地实施。
研究设计与样本
- 单盲、3期、随机、对照、非劣效性试验,在埃塞俄比亚农村招募确诊严重精神障碍(精神病性或情感性障碍)的参与者,随机分配至TSC组或PSY组。
- TSC由受督导的非医师初级卫生保健工作者提供,这些工作者接受过精神卫生差距行动规划培训并与社区卫生工作者合作;PSY为门诊精神科护士照护并辅以社区外展工作者。
- 主要终点为12个月时采用简明精神病评定量表扩展版(BPRS-E)评估的临床症状严重程度,非劣效性界值为6分;随机化按卫生机构分层,使用随机排列区组。
- 独立临床医生使用密封信封分配分组并隐藏分配,结局评估者和研究者设盲;主要结局在意向性治疗修正组分析,安全性按符合方案集分析。
- 2015年3月13日至2016年5月21日招募329名参与者(女111例、男218例),年龄25-72岁,主要为古拉格族(198例[60%])、锡尔特族(58例[18%])和马雷科族(53例[16%]);随机化后5例不符合条件,意向性治疗修正样本为324例。
主要发现
- 12个月评估完成:TSC组158例中155例(98%),PSY组166例中158例(95%)。
- 主要结局无TSC劣于PSY的证据:TSC组BPRS-E均分27.7(SD 4.7) vs PSY组27.8(SD 4.6),调整后均差0.06(90% CI -0.80至0.89);符合方案集分析(n=291)结果相似。
- 严重不良事件共47例(TSC组18例 vs PSY组29例),涉及28名参与者,包括17起施暴事件和7起导致受伤的暴力受害事件、10次自杀未遂、6次因躯体健康问题住院、4次精神科住院和3例死亡(TSC组1例 vs PSY组2例)。
- 从卫生保健部门视角,12个月时TSC的增量成本效果比为BPRS-E评分每增加一个单位节省299.82美元(95% CI -454.95至-144.69)。
关键数值与推荐
- 非劣效性界值为BPRS-E评分6分。
- 主要结局在意向性治疗修正组分析,安全性在符合方案集分析。
- TSC组BPRS-E均分27.7(SD 4.7) vs PSY组27.8(SD 4.6),调整后均差0.06(90% CI -0.80至0.89)。
- TSC增量成本效果比为每单位BPRS-E评分增加节省299.82美元(95% CI -454.95至-144.69)。
临床怎么用
- 作者认为,WHO精神卫生差距行动规划用于严重精神障碍时与现有专科照护模式具有同等成本效果,在资源匮乏地区可由受督导的非专科人员有效且安全地实施。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There have been no trials of task-shared care (TSC) using WHO's mental health Gap Action Programme for people with severe mental disorders (psychosis or affective disorder) in low-income or middle-income countries. We aimed to evaluate the efficacy and cost-effectiveness of TSC compared with enhanced specialist mental health care in rural Ethiopia. METHODS: In this single-blind, phase 3, randomised, controlled, non-inferiority trial, participants had a confirmed diagnosis of a severe mental disorder, recruited from either the community or a local outpatient psychiatric clinic. The intervention was TSC, delivered by supervised, non-physician primary health care workers trained in the mental health Gap Action Programme and working with community health workers. The active comparison group was outpatient psychiatric nurse care augmented with community lay workers (PSY). Our primary endpoint was whether TSC would be non-inferior to PSY at 12 months for the primary outcome of clinical symptom severity using the Brief Psychiatric Rating Scale, Expanded version (BPRS-E; non-inferiority margin of 6 points). Randomisation was stratified by health facility using random permuted blocks. Independent clinicians allocated groups using sealed envelopes with concealment and outcome assessors and investigators were masked. We analysed the primary outcome in the modified intention-to-treat group and safety in the per-protocol group. This trial is registered with ClinicalTrials.gov, number NCT02308956. FINDINGS: We recruited participants between March 13, 2015 and May 21, 2016. We randomly assigned 329 participants (111 female and 218 male) who were aged 25-72 years and were predominantly of Gurage (198 [60%]), Silte (58 [18%]), and Mareko (53 [16%]) ethnicity. Five participants were found to be ineligible after randomisation, giving a modified intention-to-treat sample of 324. Of these, 12-month assessments were completed in 155 (98%) of 158 in the TSC group and in 158 (95%) of 166 in the PSY group. For the primary outcome, there was no evidence of inferiority of TSC compared with PSY. The mean BPRS-E score was 27·7 (SD 4·7) for TSC and 27·8 (SD 4·6) for PSY, with an adjusted mean difference of 0·06 (90% CI -0·80 to 0·89). Per-protocol analyses (n=291) were similar. There were 47 serious adverse events (18 in the TSC group, 29 in the PSY group), affecting 28 participants. These included 17 episodes of perpetrated violence and seven episodes of violent victimisation leading to injury, ten suicide attempts, six hospital admissions for physical health conditions, four psychiatric admissions, and three deaths (one in the TSC group, two in the PSY group). The incremental cost-effectiveness ratio for TSC indicated lower cost of -US$299·82 (95% CI -454·95 to -144·69) per unit increase in BPRS-E scores from a health care sector perspective at 12 months. INTERPRETATION: WHO's mental health Gap Action Programme for people with severe mental disorders is as cost-effective as existing specialist models of care and can be implemented effectively and safely by supervised non-specialists in resource-poor settings. FUNDING: US National Institute of Mental Health.
引用
- Hanlon C, Medhin G, Dewey ME, et al. Efficacy and cost-effectiveness of task-shared care for people with severe mental disorders in Ethiopia (TaSCS): a single-blind, randomised, controlled, phase 3 non-inferiority trial. Lancet Psychiatry. 2022. PMID: 34921796. doi:10.1016/S2215-0366(21)00384-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。